本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.04
0.0000
盘后1.01-0.0250-2.42%18:00 EDT
成交量:3.19万
成交额:3.30万
市值:1,374.27万
市盈率:-0.95
高:1.05
开:1.05
低:1.02
收:1.04
数据加载中...
2019/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]